September 09, 2025 a 07:43 pm
DGX: Fundamental Ratio Analysis - Quest Diagnostics Incorporated
Quest Diagnostics Incorporated, a major player in the diagnostic testing and healthcare solutions industry, demonstrates consistent performance with a focus on innovative services. With a strong position in the healthcare sector, DGX shows resilience and potential for steady growth, though careful attention to market dynamics is advisable.
Fundamental Rating
The fundamental rating of Quest Diagnostics suggests a stable stock backed by solid performance indicators. The overall rating is 'B', reflecting consistent results in key metrics.
| Metric | Score | Score Bar |
|---|---|---|
| Overall Score | 3 | |
| Discounted Cash Flow | 4 | |
| Return on Equity | 4 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 2 |
Historical Rating
The historical performance of DGX shows a downward trend from an overall high score to a stable current score, reflecting past challenges and adjustments.
| Date | Overall Score | Discounted Cash Flow | Return on Equity | Return on Assets | Debt to Equity | Price to Earnings | Price to Book |
|---|---|---|---|---|---|---|---|
| 2025-09-09 | 3 | 4 | 4 | 4 | 1 | 2 | 2 |
| Previous | 0 | 4 | 4 | 4 | 1 | 2 | 2 |
Analyst Price Targets
The price target forecasts for DGX show analysts' expectations centered around stable price ranges, with the consensus indicating a 'Hold'.
| High | Low | Median | Consensus |
|---|---|---|---|
| $195 | $185 | $194 | $191.33 |
Analyst Sentiment
The analyst sentiment on DGX reflects a mixed outlook, with a majority leaning towards 'Hold'. Such neutral perspectives suggest cautious investment considerations.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 13 | |
| Hold | 18 | |
| Sell | 3 | |
| Strong Sell | 0 |
Conclusion
Quest Diagnostics Incorporated presents a stable investment opportunity with consistent earnings and growth potential. While its valuation metrics suggest some concerns (e.g., debt ratios), the company's robust operational foundation and market presence solidify its appeal. The analyst consensus remains largely neutral, prompting investors to weigh potential risks against steady sector growth. Market fluctuations and industry innovations may play a crucial role in future performance.